Contractual Compliance Sustains a Better Building

Any organization that owns buildings understands the importance of maintaining them with regular service calls. Many have contracts with service providers, but not all of them are met on time. If that occurs, building owners can find themselves in need of emergency repairs to their HVAC unit.

That’s not the case for today’s guest on 10 Minutes to a Better Building. Host Tyler Kern spoke with Barry Shirey, Service Team Lead at Boland, on the subject of contract compliance.

“The main focus on my service team, which includes seven, is to perform contracts on a monthly, quarterly or annual basis. It’s an important role for the company. All we do are contracts,” Shirey explained.

Before Shirey’s team became contract-specific, all service teams had to juggle those and many other types of work. The company wanted to have full focus on these contracts to ensure they were always meeting customer expectations.

“Industry-wide, the compliance for contracts is 70-85&, which is fine unless you’re in that 30-15%. For the last eight months, we’ve been 100% compliant,” Shirey said.

Being timely with contracts helps building managers avoid surprises, from something catastrophic like a system-wide shutdown to something relatively minor like unchanged filters. One simple maintenance misstep could wreak havoc on a building’s AC unit.

Shirey also noted that many are returning to buildings that have been unoccupied for over a year. “It’s a busy time, and there’s a wealth of work out there to get these buildings ready for occupancy,” Shirey added.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More